Brandenburg Kapital - News about ThinkSono GmbH

With fresh capital, the British MedTech company is expanding its team and activities in Europe and the US – Brandenburg Kapital among investors.

Potsdam - July 2025. The Potsdam-based MedTech start-up ThinkSono, developer of the world's first AI-based software for detecting deep vein thrombosis (DVT), has successfully closed an oversubscribed financing round. A total of US$6 million will flow into the company.

Together with Id4 ventures, Cur8 Capital, and leading international MedTech experts, Brandenburg Kapital is supporting the next phase of growth - from commercialization in the UK/EU to the targeted FDA approval.

With the new capital, ThinkSono is strengthening its international team and is continuing to drive expansion in Europe and the US. In parallel, multicenter clinical trials are underway in preparation for FDA approval of the ThinkSono Guidance software. The development is supported by collaborations with renowned US clinics such as NYU Langone Health, Temple Health, and UW Health.

ThinkSono is positioning itself as a pioneer in intelligent ultrasound solutions for improving patient care worldwide.

Brandenburg Kapital GmbH has been supporting the company since 2020.

Read the full article here: Article

About ThinkSono GmbH

Founded in 2016, ThinkSono has developed the world's first real-time AI ultrasound software that enables medical personnel without ultrasound training to perform TVT scans. This technology addresses the unmet global medical need for better TVT detection. In addition, ThinkSono is developing training solutions for other AI ultrasound applications to improve access to ultrasound imaging and to qualify non-ultrasound-trained healthcare professionals to perform critical ultrasound examinations. ThinkSono's TVT solution has already been tested in hospitals in the UK and the EU and is now being introduced in the US.

You can find further information at: www.brandenburg-kapital.de, www.thinksono.com